Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).
Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Read More

Overview

Feature Articles

Latest Lung Cancer News and Research

RANBP2 identified as key regulator in the progression of multiple solid tumors

RANBP2 identified as key regulator in the progression of multiple solid tumors

Multimodal AI system improves lung cancer screening accuracy

Multimodal AI system improves lung cancer screening accuracy

Cancer rates are climbing in younger adults and researchers want to know why

Cancer rates are climbing in younger adults and researchers want to know why

New predictive algorithms improve early detection of undiagnosed cancers

New predictive algorithms improve early detection of undiagnosed cancers

Study introduces heart-sparing technique in lung cancer radiotherapy

Study introduces heart-sparing technique in lung cancer radiotherapy

Learning from every patient: New radiotherapy technique aims to protect the heart during lung cancer treatment

Learning from every patient: New radiotherapy technique aims to protect the heart during lung cancer treatment

Study uncovers 'cell of origin' of the second most common lung cancer

Study uncovers 'cell of origin' of the second most common lung cancer

Study links pregnancy specific genes to poorer lung cancer outcomes in women

Study links pregnancy specific genes to poorer lung cancer outcomes in women

Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

New method improves RMST analysis for clinical and epidemiological studies

New method improves RMST analysis for clinical and epidemiological studies

Historic decline in smoking across the United States largely driven by young adults

Historic decline in smoking across the United States largely driven by young adults

Novel cancer immunotherapy approach could complement existing CAR-T treatments

Novel cancer immunotherapy approach could complement existing CAR-T treatments

lncRNAs shape the tumor microenvironment and drive cancer development

lncRNAs shape the tumor microenvironment and drive cancer development

Manipulating a master regulator prevents tumor growth in mice

Manipulating a master regulator prevents tumor growth in mice

Expansion of mutant blood cells linked to worse cancer outcomes

Expansion of mutant blood cells linked to worse cancer outcomes

AI tool helps GPs spot lung cancer risk months earlier

AI tool helps GPs spot lung cancer risk months earlier

Liquid biopsy offers new hope for early cancer detection

Liquid biopsy offers new hope for early cancer detection

New RNA-based blood test offers insight into cancer and tissue damage

New RNA-based blood test offers insight into cancer and tissue damage

The dual role of microRNAs in lung cancer progression and suppression

The dual role of microRNAs in lung cancer progression and suppression

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.